About this trial
This is a multicenter prospective cohort study in which patients were evaluated by inclusion and exclusion criteria before phase II revision surgery. Eligible patients will be included in this study after signing the informed consent form. After the second stage revision, according to the patient's symptoms and examination results, the attending physician used a reasonable antibiotic treatment scheme (including intravenous and oral medication). All patients voluntarily participated in the study and signed informed consent. During the treatment period, all prospective patients underwent clinical evaluation at the time points of 1, 3, 6, 12, 18 and 24 months after the start of antibiotic treatment after phase II revision. The infection control rate of patients was evaluated by follow-up at least 2 years after operation, so as to analyze the effect of antibiotic treatment course after two-stage revision of periprosthetic joint infection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
1. Follow-up data not available. 2. Researchers judge that patients no longer meet the standards of the study due to compliance problems
Trial population
Patients who underwent secondary replantation surgery for prosthetic joint infection at the First Affiliated Hospital of Fujian Medical University and other sub-centers were selected.
Trial design
Cohort
Prospective
Treatments tested in this trial
Antibiotics treatment
DrugAfter receiving intravenous antibiotics treatment for 2 weeks, and clinician determines whether to continue with any antibiotics.
Treatment groups
Trial outcomes
Primary outcomes
Clearance rate of infection
Number of subjects with infection cleared/total number of subjects who completed follow-up
Sponsors and contacts
Click on the lead sponsor to view all of their trials.